The recipient of the pioneering genetically modified pig kidney transplant succumbs almost two months post-operation.

Richard “Rick” Slayman, the inaugural recipient of a genetically modified pig kidney transplant, has passed away nearly two months following the procedure, as confirmed by both his family and the hospital where the surgery took place.

The inaugural recipient of a genetically modified pig kidney transplant, Richard “Rick” Slayman, has passed away almost two months following the groundbreaking procedure, as confirmed by his family and Massachusetts General Hospital where the surgery took place in March. Surgeons had initially anticipated the pig kidney would function for a minimum of two years.

Slayman, aged 62 from Weymouth, Massachusetts, underwent the transplant after facing complications from his previous kidney transplant in 2018. Dialysis complications prompted his doctors to recommend the innovative pig kidney transplant.

The transplant team expressed deep sorrow at Slayman’s passing and extended condolences to his family, clarifying that there were no indications his death was directly linked to the transplant.

Slayman’s family expressed gratitude to his medical team, highlighting the additional time the xenotransplantation afforded them with him. Their statement emphasized Slayman’s hope to inspire others in need of transplants, echoing the sentiment that his legacy of hope and optimism will endure.

Xenotransplantation, a procedure utilizing animal organs to heal human patients, has faced historical challenges due to immune system rejection. However, recent advancements, including genetically modified pigs with more compatible organs, offer potential solutions to the growing demand for organ transplants.

The tragic passing of Slayman underscores the urgent need for solutions to address the extensive waiting list for organ transplants, particularly for kidney patients, where thousands die annually before receiving a transplant.